Dear all,

registration for the 27th Protein Structure Determination in Industry (PSDI) 
meeting, 3-5 November 2019, is now open:

https://psdi2019.org/

The meeting will be held at the Wellcome Genome Campus, Hinxton, 
Cambridgeshire, UK. Workshops will take place on Sunday the 3rd of November, 
followed by a welcome reception. Scientific sessions and exhibition will be 
held on Monday the 4th and Tuesday the 5th of November, with a conference 
dinner in central Cambridge on the 4th.

Important dates:
  - Early Bird registration closes 22nd July 2019
  - Registration closes: 28th October 2019

Scientific talks will cluster around the following major themes:
  - structure and biophysics based drug design stories
  - cryoEM in a pharmaceutical setting
  - popular biophysics techniques, eg. HDX-MS
  - popular drug discovery trends, eg. degraders

Workshops will include three consecutive sessions about biophysics, 
crystallography and cryoEM.

If you have an exciting scientific story to share in form of a talk (especially 
on HDX and degraders), please feel free to get in touch with the organisers: 
Judit Debreczeni (judit dot debreczeni at astrazeneca dot com) or Chris 
Phillips (chris dot phillips at astrazeneca dot com). Exhibitors or sponsors: 
please use the registration pages to book your place.

Confirmed speakers include:
  - Gerd Bader (Boehringer Ingelheim)
  - Celine Be (Novartis)
  - Gerard Bricogne (Global Phasing)
  - Ana CasaƱal (MRC-LMB)
  - Chun-wa Chung (GSK)
  - Paul Emsley (MRC-LMB)
  - Richard Henderson (keynote lecture, MRC-LMB)
  - Rob van Montfort (ICR)
  - Djordje Musil (Merck)
  - Herbert Nar (Boehringer Ingelheim)
  - Colin Palmer (CCP-EM)
  - Alexey Rak (Sanofi)
  - Armin Ruf (Roche)
  - Kasim Sader (ThermoFisher)
  - Martina Schaefer (Bayer)
  - Stacey Southall (Sosei Heptares)
  - Pamela Williams (Astex)

This year's meeting is organised by AstraZeneca UK, supported by Hg3 
Conferences.

We are looking forward to seeing you at the PSDI 2019!

Judit Debreczeni and Chris Phillips (AZ UK)

---
Judit Debreczeni
Associate Principal Scientist
SBF, Discovery Sciences
AstraZeneca

AstraZeneca
Darwin (310) Building
Cambridge Science Park
Milton Road
Cambridge
CB4 0WG
UK

________________________________


AstraZeneca UK Limited is a company incorporated in England and Wales with 
registered number:03674842 and its registered office at 1 Francis Crick Avenue, 
Cambridge Biomedical Campus, Cambridge, CB2 0AA.

This e-mail and its attachments are intended for the above named recipient only 
and may contain confidential and privileged information. If they have come to 
you in error, you must not copy or show them to anyone; instead, please reply 
to this e-mail, highlighting the error to the sender and then immediately 
delete the message. For information about how AstraZeneca UK Limited and its 
affiliates may process information, personal data and monitor communications, 
please see our privacy notice at 
www.astrazeneca.com<https://www.astrazeneca.com>

########################################################################

To unsubscribe from the CCP4BB list, click the following link:
https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=CCP4BB&A=1

Reply via email to